Teva launch takes it into the generic OTC market
The company has launched an analgesic, gastrointestinal, cough and cold and allergy range to mark its entry into the sector, ahead of the launch of a women's health line early next year.
The range will be supported by a heavyweight, national press campaign, which will commence this autumn. OTC brand manager Ryan Ruscoe said
the launch of the range will also be supported by training packages for pharmacists and counter assistants.
He added that the decision to move into the OTC market was due to the UK government continuing to push self-care to patients. Mr Ruscoe said: "[The launch] is to keep ahead of the trends as the self-medication market seems more important.
"We are launching now as the cold and flu season will soon be upon us and we have a range of cold and flu products."
Teva commercial director Kim Innes said the company planned to generate increased sales in 2015, with generics commanding 70 per cent of its market.
Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments. However, any comments deemed to be libellous will be removed
